Every formulation, reviewed by a doctor before it reaches a shelf
Our medical advisory board reviews Ozenca's formulations, safety, and labelling before launch. The board advises Ozenca internally and does not see patients — for medical advice, please consult your own doctor.
Dr. Priyanka
MBBS, MS — Obstetrics & GynaecologyAdvises on OvaZenca and Clin-diva — maternal, hormonal, and intimate-health formulations.
Dr. Jal
MD, DNB — Gastroenterologist, Consultant, Apollo HospitalAdvises on RifaZenca, GutZenca, and UDCORA-300 — gut and liver health formulations.
Dr. Jyoti
MBBS, MD — PathologyReviews lab-correlation, diagnostic accuracy, and safety labelling across the catalogue.
Dr. Prateek Chaudhary
MBBS, MD (Medicine), DM (Cardiology), EP Fellowship — Senior Consultant, Interventional Cardiology, Asian Institute of Medical SciencesSenior medical advisor providing general clinical oversight across the Ozenca catalogue.
Advisory, not clinical consultation
Our board's role is to advise Ozenca on product formulation, safety, and compliance — it does not see patients or issue prescriptions. If you're looking for medical advice or a prescription, please consult your own doctor or nearest pharmacy.
Maternal & Gynaecology
Advises on hormonal balance, PCOS-related, and intimate-health formulations.
Gastroenterology
Advises on gut-infection, microbiome, and liver-support formulations.
Pathology & Clinical Oversight
Reviews diagnostics-linked safety and plain-language labelling across the catalogue.